NIR-II Fluorescence In Vivo Imaging System is a kind of noninvasive whole-body imaging technique. In this experiment, 200 μL MNPH2 aqueous solution (800 μg/mL) was also intravenously injected into tumor-bearing nude mice. The mice (n=3) were kept in anesthesia state using isoflurane mixed with oxygen and excited by an 808 nm internal laser at a power of 2.0 W and exposure time of 100 ms. The images collection time was set at pre-injection, 2, 4, 8, 12, and 24 h post intravenous injection of MNPH2. The fluorescence intensities of NIR-II images were analyzed using the software Image J. To verify the biodistribution and accumulation performance of MNPH2 in vivo, the tumor-bearing mice were sacrificed at 24 h after imaging and major tissues including heart, liver, spleen, lung, kidney, and tumor were imaged, and the signal intensities were quantitatively analyzed.
For in vivo PA imaging, Hep-2 tumor-bearing nude mice (n=3) were intravenously injected with 200 μL MNPH2 aqueous solution (800 μg/mL) via the tail vein. The above MSOT platform was conducted to obtain images of tumor regions at pre-injection, 2 h, 4 h, 8 h, 12 h, and 24 h post injection. The NIR excitation wavelength of MSOT scanner consists of a range of 680–980 nm. Besides, the PA signal intensities of tumor site at different points were also quantitatively analyzed.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.